AML-442: RAS Mutations Negate the Favorable Impact of NPM1 in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA
2025 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(25)01670-2
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
39
Papers
157
Citations
6
h-index
4
i10-index
Ying Huang is an academic researcher from Fujian Medical University. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Chronic Lymphocytic Leukemia Research & Chronic Myeloid Leukemia Treatments. The author has an h-index of 6, co-authored 34 publications.
ORCID: 0009-0000-3117-145XClick to start Chat